Product NDC: | 0049-3160 |
Proprietary Name: | VFEND |
Non Proprietary Name: | VORICONAZOLE |
Active Ingredient(s): | 40 mg/mL & nbsp; VORICONAZOLE |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0049-3160 |
Labeler Name: | Roerig |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021630 |
Marketing Category: | NDA |
Start Marketing Date: | 20030328 |
Package NDC: | 0049-3160-44 |
Package Description: | 1 BOTTLE in 1 CARTON (0049-3160-44) > 75 mL in 1 BOTTLE |
NDC Code | 0049-3160-44 |
Proprietary Name | VFEND |
Package Description | 1 BOTTLE in 1 CARTON (0049-3160-44) > 75 mL in 1 BOTTLE |
Product NDC | 0049-3160 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VORICONAZOLE |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20030328 |
Marketing Category Name | NDA |
Labeler Name | Roerig |
Substance Name | VORICONAZOLE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |